{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:48:37Z","timestamp":1758476917835},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comprehensive Psychiatry"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.comppsych.2014.04.008","type":"journal-article","created":{"date-parts":[[2014,4,12]],"date-time":"2014-04-12T21:45:50Z","timestamp":1397339150000},"page":"1391-1397","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Relationships between IGF-1, schizophrenia, and treatment of metabolic syndrome"],"prefix":"10.1016","volume":"55","author":[{"given":"Aysegul","family":"Demirel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer Faruk","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Em\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaattin","family":"Duran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mufit","family":"U\u011fur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.comppsych.2014.04.008_bb0005","first-page":"152","article-title":"The metabolic syndrome in patients with severe mental illnesses. Prime care companion","volume":"6","author":"Toalson","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/ajp.154.4.1","article-title":"Practice guidelines for the treatment of patients with schizophrenia","volume":"154","author":"American Psychiatric Association","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0015","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1001\/jama.298.15.1794","article-title":"Severe mental illness and risk of cardiovascular disease","volume":"298","author":"Newcomer","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0303-7207(98)00035-5","article-title":"Asphyxial brain injury \u2013 the role of the IGF system","volume":"140","author":"Gluckman","year":"1998","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1192\/bjp.184.5.383","article-title":"Foetal origins of schizophrenia: testable hypotheses of genetic and environmental influences","volume":"184","author":"Abel","year":"2004","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0306-4530(92)90039-A","article-title":"Insulin like growth factors (IGF): Implications of aging","volume":"17","author":"Cheo","year":"1992","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0035","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1210\/jcem.86.9.7868","article-title":"Association of IGF-I levels with muscle strength and mobility in older women","volume":"86","author":"Cappola","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0040","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1083\/jcb.110.4.1307","article-title":"Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors","volume":"110","author":"Caroni","year":"1990","journal-title":"J Cell Biol"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0045","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000012276","article-title":"Quality of life and cognitive function in patients with pituitary insufficiency","volume":"67","author":"Burman","year":"1998","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0050","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0920-9964(03)00180-4","article-title":"Do insulin-like growth factors underlie associations of birth complications, fetal and pre-adult growth with schizophrenia?","volume":"67","author":"Gunnell","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0055","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.mehy.2011.06.001","article-title":"Recombinant human IGF-1 for patients with schizophrenia","volume":"77","author":"Khalil","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pnpbp.2013.01.008","article-title":"Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients","volume":"44","author":"Palomino","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0065","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1176\/appi.ajp.2007.07020233","article-title":"Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia","volume":"164","author":"Venkatasubramanian","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0269881107075509","article-title":"Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidemia","volume":"21","author":"Barnett","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0075","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/jnci\/92.18.1472","article-title":"Role of the insulin-like growth factor family in cancer development and progression","volume":"92","author":"Yu","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0080","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3949\/ccjm.69.12.990","article-title":"The metabolic syndrome: A tug-of-war with no winner","volume":"69","author":"Brotman","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0085","first-page":"261","article-title":"Insulin-like growth factor-I in the therapy of non-insulin-dependent diabetes mellitus and insulin resistance","volume":"22","author":"Froesch","year":"1996","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1464-5491.2003.00827.x","article-title":"The role of the growth hormone\u2013insulin-like growth factor axis in glucose homeostasis","volume":"20","author":"Holt","year":"2003","journal-title":"Diabet Med"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0095","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2337\/diabetes.50.7.1539","article-title":"Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism","volume":"50","author":"Sjogren","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0100","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/S0140-6736(02)08655-5","article-title":"Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study","volume":"359","author":"Sandhu","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0105","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/aje\/kwh289","article-title":"Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and cardiovascular disease risk factors in young black men and white men: The CARDIA Male Hormone Study","volume":"160","author":"Colangelo","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s001250051134","article-title":"Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats","volume":"42","author":"Boni-Schnetzler","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0115","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1210\/endo.142.9.8390","article-title":"IGF-I treatment reduces hyperphagia, obesity, and hypertension in metabolic disorders induced by fetal programming","volume":"142","author":"Vickers","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0120","series-title":"DSM-IV Eksen I Bozukluklar\u0131 (SCID-I) i\u00e7in Yap\u0131land\u0131r\u0131lm\u0131\u015f Klinik G\u00f6r\u00fc\u015fme-Klinik Versiyon","author":"\u00c7orap\u00e7\u0131o\u011flu","year":"1999"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0125","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: Report of the National Heart, Lung and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.psychres.2011.12.014","article-title":"Abnormality of glycometabolism related factors in non-psychotic offspring of schizophrenic patients","volume":"198","author":"Yang","year":"2012","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0140","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/sj.ijo.0803750","article-title":"Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity","volume":"32","author":"Wu","year":"2008","journal-title":"Int J Obes"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0145","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1515\/CCLM.2007.265","article-title":"Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects","volume":"45","author":"Akanji","year":"2007","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajmg.b.30396","article-title":"IGF1, growth pathway polymorphisms and schizophrenia: A pooling study","volume":"144","author":"Gunnell","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/YPG.0b013e3283351167","article-title":"Polymorphic CA repeat in IGF-I gene: lack of association with schizophrenia","volume":"20","author":"Bonvicini","year":"2010","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s004210050655","article-title":"Leg power and dehydroepiandrosterone sulfate, insulin-like growth factor-I and testosterone in healthy active elderly people","volume":"82","author":"Kostka","year":"2000","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0165","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1043-2760(98)00126-X","article-title":"Circulating IGF-I: New Perspectives for a New Century","volume":"10","author":"Rosen","year":"1999","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0170","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related Disorders\u2014a systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0175","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0180","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/sj.ejcn.1602554","article-title":"Prevalence of the metabolic syndrome in Turkish adults","volume":"61","author":"Kozan","year":"2007","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0185","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2458-6-92","article-title":"Prevalence of metabolic syndrome-related disorders in a large adult population in Turkey","volume":"6","author":"Sanisoglu","year":"2006","journal-title":"BMC Public Health"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0190","first-page":"159","article-title":"Prevalence of the metabolic syndrome in a rural Turkish population: Comparison and concordance of two diagnostic criteria","volume":"38","author":"Gemalmaz","year":"2008","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0195","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1464-5491.2007.02092.x","article-title":"Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia","volume":"24","author":"Spelman","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.schres.2006.08.017","article-title":"Does antipsychotic polypharmacy increase the risk for metabolic syndrome?","volume":"89","author":"Correl","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0205","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1176\/appi.psy.47.6.491","article-title":"The prevalence of the metabolic syndrome in psychiatric inpatients with primary psychotic and mood disorders","volume":"47","author":"Bermudes","year":"2006","journal-title":"Psychosomatics"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0210","first-page":"13","article-title":"\u015eizofrenide metabolik sendrom s\u0131kl\u0131\u011f\u0131, metabolik sendromun \u00f6zellikleri ve kullan\u0131lan antipsikotiklerle ili\u015fkisi","volume":"46","author":"Kaya","year":"2009","journal-title":"N\u00f6ropsikiyatri Ar\u015fivi"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0215","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4088\/JCP.v58n0304","article-title":"Clozapine and associated diabetes mellitus","volume":"58","author":"Popli","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.comppsych.2014.04.008_bb0220","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-244X-7-14","article-title":"Metabolic syndrome in Thai schizophrenic patients: A naturalistic one-year follow-up study","volume":"7","author":"Srisurapanont","year":"2007","journal-title":"BMC Psychiatry"}],"container-title":["Comprehensive Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X14000959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X14000959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T13:15:22Z","timestamp":1565356522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010440X14000959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0010440X14000959"],"URL":"https:\/\/doi.org\/10.1016\/j.comppsych.2014.04.008","relation":{},"ISSN":["0010-440X"],"issn-type":[{"value":"0010-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationships between IGF-1, schizophrenia, and treatment of metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Comprehensive Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.comppsych.2014.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}